GLP Q1 2026 Earnings Massive EPS Surprise of 455 Overshadows Lack of Revenue Disclosure Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues Tutor Perini Corporation TPC Q1 2026 Earnings Strong EPS Beat Amid Revenue Disappointment Dyne Therapeutics Q1 2026 Earnings EPS Beat Amid Ongoing Clinical Focus ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain CCB Q1 2026 Earnings EPS Falls Short as Profitability Pressures Mount